Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Persistently low alkaline phosphatase (ALP) is a red flag for ALPL gene mutations behind hypophosphatasia, a genetic condition that disrupts bone and tooth mineralization and can cause fractures, early tooth loss, bone pain, and muscle weakness. Standard next steps include repeating ALP with age- and sex-specific reference ranges, ruling out mimics like zinc or magnesium deficiency, malnutrition, hypothyroidism, celiac disease, and bisphosphonate use, then measuring vitamin B6 (pyridoxal 5'-phosphate) and urine phosphoethanolamine before ALPL genetic testing and referral to a metabolic bone or genetics specialist. Symptom severity, family history, and lab timing all change how urgently these steps should happen, and there are several important details to consider below. Because low ALP findings are easy to dismiss yet can explain years of unexplained bone, dental, and fatigue symptoms, mapping your own symptom pattern first makes those specialist visits far more productive. Take a free, instant, online symptom check to see which conditions may match what you are experiencing and get clear guidance on your next steps.
Last reviewed for medical accuracy: 08/18/2026
When you get routine blood work, one of the numbers you’ll see is alkaline phosphatase (ALP). If you’ve ever wondered, “what is your alkaline phosphatase?” here’s a quick answer: it’s an enzyme made primarily by your liver, bones and intestines. It plays a key role in bone mineralization and liver function. Most people focus on high ALP levels, but low ALP results also deserve attention—particularly because they can point to rare gene mutations.
Alkaline phosphatase is measured in units per liter (U/L). Reference ranges vary by lab, age and sex, but are generally:
Factors that can lower ALP include malnutrition, certain medications, and—importantly—genetic disorders. A persistently low ALP reading should prompt a closer look.
Mildly low ALP can be benign. But consistently low levels (< 40 U/L in adults) may signal:
Because these conditions are uncommon, doctors often overlook low ALP. That’s why understanding why your lab number fell below normal matters.
Not everyone with low ALP has a genetic mutation, but if you notice:
you should investigate further.
If these symptoms align, a genetic cause becomes more likely.
Confirm Your Lab Result
• Repeat the ALP measurement—ideally fasting, at the same lab.
• Check related markers: calcium, phosphate, vitamin D, liver enzymes.
Review Medications and Lifestyle
• Some drugs (e.g., certain antiseizure medications) can lower ALP.
• Severe malnutrition, zinc or magnesium deficiency may play a role.
Assess Clinical Context
• Compile your symptoms, family history of fractures or dental issues.
• Note any childhood growth delays or unexplained liver problems.
Consider Genetic Testing
• If low ALP is persistent and unexplained, talk to a genetic counselor or specialist.
• Testing can identify ALPL mutations (hypophosphatasia) or other gene changes.
• Results guide prognosis, treatment and family planning.
Consult Specialists
• Endocrinologist (bone metabolism)
• Geneticist or genetic counselor
• Hepatologist (if liver involvement is suspected)
Plan Management and Follow-Up
• Hypophosphatasia treatments range from enzyme replacement therapy to pain management.
• Nutritional support: adequate vitamin D, calcium and protein.
• Physical therapy for muscle strength and balance.
Monitor Over Time
• Regular bone density scans and dental exams.
• Repeat labs every 6–12 months, or as advised by your specialist.
It’s natural to worry when a lab result falls outside the reference range. Remember:
If you’re unsure where to start, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you organize your symptoms and decide which specialists to see.
When you speak with your primary care physician or specialist, be prepared to discuss:
Bring copies of past lab results and any imaging reports. Clear communication will speed up diagnosis.
Don’t let a single lab result go unexamined. If you have concerns about low ALP or any persistent symptoms, always speak to a doctor—especially for anything that could be life threatening or serious. Discuss your risk, ask about genetic testing, and follow through with recommended monitoring and treatments.
(References)
* Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19. PMID: 26893260.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. PMID: 28888853.
* Mornet E. Hypophosphatasia. Metabolism. 2018 May;82:142-155. doi: 10.1016/j.metabol.2017.08.013. Epub 2017 Sep 20. PMID: 28939177.
* Del Angel G, Reynders J, Negron C, Steinbrecher T, Mornet E. Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia. Hum Mutat. 2020 Jul;41(7):1250-1262. doi: 10.1002/humu.24010. Epub 2020 Mar 18. PMID: 32160374; PMCID: PMC7317754.
* Mornet E, Taillandier A, Domingues C, Dufour A, Benaloun E, Lavaud N, Wallon F, Rousseau N, Charle C, Guberto M, Muti C, Simon-Bouy B. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021 Feb;29(2):289-299. doi: 10.1038/s41431-020-00732-6. Epub 2020 Sep 24. PMID: 32973344; PMCID: PMC7868366.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.
* Riancho JA. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar;112(3):289-296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Lewiecki EM. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024 Mar;35(3):431-438. doi: 10.1007/s00198-023-06844-1. Epub 2023 Nov 20. PMID: 37982857; PMCID: PMC10866785.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.